European instances of the VELYS Robotic-Assisted Solution initiated by Johnson & Johnson
In a groundbreaking development, Johnson & Johnson MedTech has announced the introduction of the VELYS Robotic-Assisted Solution for Unicompartmental Knee Arthroplasty (UKA) procedures in Europe. This innovative technology offers numerous benefits and advantages, aimed at overcoming the challenges faced by surgeons in manual partial knee replacement.
## Enhanced Precision and Improved Outcomes
The VELYS Robotic-Assisted Solution (VRAS) platform equips surgeons with real-time data, enabling accurate bone cuts and customised implant placement tailored to each patient's unique anatomy. The system offers precise 3D positioning and insights to help achieve optimal balance and alignment, enhancing joint stability.
The precision of the system leads to a better fit and alignment of the implant, potentially resulting in longer-lasting results. Enhanced precision and alignment reduce the risk of complications during and after surgery.
## Patient Benefits
The robotic assistance allows for smaller incisions, reducing tissue trauma and promoting faster healing. The minimally invasive approach results in less tissue damage and reduced post-operative pain, allowing patients to expect quicker recovery times and an earlier return to normal activities.
Another significant advantage is that the VRAS UKA clinical application does not require a pre-operative CT scan, reducing radiation exposure and streamlining the pre-surgical process.
## Advanced Features
The VRAS UKA clinical application is designed to work with the SIGMA HP Partial Knee Implant and INTUITION INSTRUMENTS. The system provides personalised surgical plans, enhancing patient-specific operative decisions. Surgeons receive real-time guidance during the procedure, supporting precise execution and decision-making.
## A Significant Advancement
The VELYS Robotic-Assisted Solution represents a significant advancement in UKA procedures, offering precision, personalised care, and improved patient outcomes. Despite the benefits, UKA is underutilised due to complexities such as smaller incisions and lack of visibility. However, with the introduction of the VRAS, these barriers are being addressed, transforming patient outcomes and representing a significant advancement in tailored solutions.
Dr Pieter-Jan Vandekerckhove, who performed the first surgeries in Belgium, is excited about the technology. He commented that the VELYS UKA clinical application enhances accuracy, consistency, and precision compared to manual techniques.
As an aging population demands personalised treatments in knee replacement surgery, the VELYS Robotic-Assisted Solution offers a cost-effective alternative to Total Knee Arthroplasty (TKA), providing clinical benefits and improved patient outcomes. The SIGMA HP Partial Knee Implant has demonstrated significantly better 15-year survivorship compared to its class, further underscoring the potential of this innovative technology.
The VELYS Robotic-Assisted Solution, with its advanced technology, assists surgeons in achieving optimal bone cuts and implant placement, ultimately reducing complications and promoting faster healing for patients. This innovative system also streamlines the pre-surgical process by eliminating the need for a pre-operative CT scan, thereby reducing radiation exposure.
The VELYS Robotic-Assisted Solution, with its precision and personalised care, represents a significant advancement in health-and-wellness, medical-conditions, and health-technology, offering improved patient outcomes and a cost-effective alternative to Total Knee Arthroplasty (TKA). This solution, when combined with the SIGMA HP Partial Knee Implant, provides science-backed benefits for those requiring knee replacement surgeries.
